Because each peptide acts through different biological pathways, researchers often investigate the combination to better understand how multiple regenerative mechanisms may interact
Generation 2: Tirzepatide, dual-agonist GLP-1 + GIP Tirzepatide adds the glucose-dependent insulinotropic peptide (GIP) receptor to the GLP-1 target
It also indirectly increases insulin sensitivity in skeletal muscle by promoting microvessel recruitment, which may enhance local insulin action [69]
Occasionally, signs of acute toxicity may be absent for 1248 hours following administration, after which a critical phase may develop, characterised by pulmonary oedema, vasomotor collapse, cyanosis, acute hepatic failure, coma, and death of the animal